Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
J Pediatr Hematol Oncol ; 44(7): 419-420, 2022 10 01.
Article in English | MEDLINE | ID: mdl-36054901

ABSTRACT

Data regarding the outcomes of hematopoietic stem cell transplant (HSCT) for the management of SAMD9L -associated ataxia-pancytopenia syndrome remains limited. We depict the case of a 2-month-old male with a novel mutation in the SAMD9L gene, presenting with respiratory failure, pancytopenia and severe developmental delay. He experienced graft failure 2 months after a 4/6 HLA-matched cord HSCT. At 9 months old, an unsuccessful unrelated donor search prompted a haploidentical HSCT with successful engraftment. He sustains excellent donor chimerism and has improved developmentally over 2 years posttransplant. This case demonstrates haploidentical HSCT as a viable option for patients with SAMD9L mutation and no acceptable unrelated donor.


Subject(s)
Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Pancytopenia , Bone Marrow Transplantation , Cerebellar Ataxia , Humans , Infant , Male , Mutation , Transplantation Conditioning , Unrelated Donors
2.
J Pediatr Hematol Oncol ; 44(1): e134-e137, 2022 Jan 01.
Article in English | MEDLINE | ID: mdl-34001792

ABSTRACT

To this day, there are limited data about the effects and management of coronavirus disease infection in pediatric patients with sickle cell disease. We present the management and successful clinical course of an 8-year-old female with homozygous sickle cell disease (SS) and severe acute chest syndrome secondary to coronavirus disease 2019 infection, complicated by cortical vein thrombosis.


Subject(s)
Anemia, Sickle Cell/complications , COVID-19/complications , Systemic Inflammatory Response Syndrome/complications , Anemia, Sickle Cell/pathology , Anemia, Sickle Cell/therapy , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , COVID-19/pathology , COVID-19/therapy , Ceftriaxone/therapeutic use , Child , Erythrocyte Transfusion , Female , Humans , Intensive Care Units , Systemic Inflammatory Response Syndrome/pathology , Systemic Inflammatory Response Syndrome/therapy
3.
Bol Asoc Med P R ; 103(1): 9-13, 2011.
Article in Spanish | MEDLINE | ID: mdl-21698914

ABSTRACT

The purpose of the study was to determine if an educational program for parents of newborns can be useful to prevent Shaken Baby Syndrome in Puerto Rican families. Staff training was performed, parents observed an educational video & infant crying management strategies were discussed. Pre-post tests, follow up phone calls and medical chart reviews (53%) were conducted. A total of 65 newborns participated (62 mothers, 11 fathers). Parents reported that 50% had college studies, 78.7% lived together and 83.1% had government insurance. Pre-post tests demonstrated increase in knowledge (p < 0.05). Over 75% were contacted; 94% recalled learned strategies & 98% reported the infants had been well. Two infants were removed from home; no incidents of head trauma were reported. Almost half (44.5%) indicated taking care of the baby was difficult; managing the baby's crying was most difficult. All reported the program helped them. The program should be offered in other hospitals.


Subject(s)
Parents/education , Shaken Baby Syndrome/prevention & control , Adolescent , Female , Humans , Infant , Infant, Newborn , Male , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...